“Kangwanda” completed a new round of financing to accelerate the research and development of oncolytic virus pipeline products
Visit the original URL Chuangyebang was informed that recently, Kangwanda, an oncolytic virus drug developer, announced the completion of a new round of financing and the introduction of strategic partners. This round of financing was jointly participated by Dongheng Industrial Group, Huafang Capital and Blue Mountain Investment. It is understood that the funds obtained from […]